US Patent Issued to Fresenius Medical Care Holdings on April 14 for "Lipopolysaccharide (LPS) aptamers and associated methods" (Tennessee Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,972, issued on April 14, was assigned to Fresenius Medical Care Holdings Inc. (Waltham, Mass.).

"Lipopolysaccharide (LPS) aptamers and associated methods" was invented by Tao Jiang (Knoxville, Tenn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described are a number of aptamers that are specific to bind with lipopolysaccharide (LPS), and associated methods."

The patent was filed on Feb. 2, 2022, under Application No. 17/591,485.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12...